The Effects of Qufeng Tongqiao Cough-Relieving Decoction (祛风通窍止咳方) on Cough Sensitivity,TRPV4 in Lung and Nasal Mucosal Tissues,and Neurogenic Inflammation in a Guinea Pig Model of Upper Airway Cough Syndrome
|更新时间:2025-03-06
|
The Effects of Qufeng Tongqiao Cough-Relieving Decoction (祛风通窍止咳方) on Cough Sensitivity,TRPV4 in Lung and Nasal Mucosal Tissues,and Neurogenic Inflammation in a Guinea Pig Model of Upper Airway Cough Syndrome
Journal of Traditional Chinese MedicineVol. 66, Issue 5, Pages: 518-525(2025)
LUO Jingshu,MA Jianling,SHI Liqing,et al.The Effects of Qufeng Tongqiao Cough-Relieving Decoction (祛风通窍止咳方) on Cough Sensitivity,TRPV4 in Lung and Nasal Mucosal Tissues,and Neurogenic Inflammation in a Guinea Pig Model of Upper Airway Cough Syndrome[J].Journal of Traditional Chinese Medicine,2025,66(05):518-525.
LUO Jingshu,MA Jianling,SHI Liqing,et al.The Effects of Qufeng Tongqiao Cough-Relieving Decoction (祛风通窍止咳方) on Cough Sensitivity,TRPV4 in Lung and Nasal Mucosal Tissues,and Neurogenic Inflammation in a Guinea Pig Model of Upper Airway Cough Syndrome[J].Journal of Traditional Chinese Medicine,2025,66(05):518-525.DOI: 10.13288/j.11-2166/r.2025.05.013.
The Effects of Qufeng Tongqiao Cough-Relieving Decoction (祛风通窍止咳方) on Cough Sensitivity,TRPV4 in Lung and Nasal Mucosal Tissues,and Neurogenic Inflammation in a Guinea Pig Model of Upper Airway Cough Syndrome
To investigate the potential mechanism of action of the
Qufeng Tongqiao Cough
-
relieving Decoction
(祛风通窍止咳方, QTCD) in the treatment of upper airway cough syndrome (UACS).
Methods
2
Twenty-four guinea pigs were randomly divided into blank group, model group, traditional Chinese medicine (TCM) group, and inhibitor group, with six guinea pigs in each group. Except for the blank group, guinea pigs were sensitized with ovalbumin and aluminum hydroxide via intraperitoneal injection, followed by ovalbumin nasal drops combined with smoke exposure to establish the UACS model. After modeling, the TCM group was administered QTCD 0.9 g/(100 g·d) by gavage, the inhibitor group received the transient receptor potential vanilloid receptor 4 (TRPV4) inhibitor GSK2193874 1 mmol/L, 5 min by nebulisation, and the blank group and model group were given 2 ml/(100 g·d) normal saline by gavage once daily. After 7 days of treatment, a cough provocation test was performed using 0.4 mol/L citric acid. The levels of IgE in serum and inflammatory cytokines, including interleukin-6 (IL-6), interleukin-8 (IL-8) in serum, bronchoalveolar lavage fluid (BALF), and nasal lavage fluid (NLF) were detected by enzyme-linked immunosorbent assay (ELISA). Histopathological changes in lung and nasal mucosal tissues were observed by hematoxylin-eosin (HE) staining. Immunohistochemistry was used to detect the protein levels of TRPV4, substance P (SP), and calcitonin gene-related peptide (CGRP) in lung and nasal mucosal tissues. Real-time polymerase chain reaction (Real-time PCR) was used to detect the mRNA expression of
TRPV4
,
SP
, and
CGRP
in lung tissues.
Results
2
HE staining showed significant structural damage and infiltration of inflammatory cells in the lung and nasal mucosal tissues in the model group, while the TCM group and inhibitor group showed improved pathological changes. Compared with the blank group, the model group showed increased cough frequency, serum IgE level, and IL-6 and IL-8 levels in serum, BALF, and NLF. The protein levels of TRPV4, SP, and CGRP in lung and nasal mucosal tissues and their mRNA e
xpression were elevated (
P
<0.05 or
P
<0.01). Compared with the model group, the TCM group and inhibitor group showed reduced cough frequency, serum IgE level, and
TRPV4
and
SP
mRNA expression in lung tissues. The TCM group showed reduced IL-6 and IL-8 levels in serum, BALF, and NLF, and reduced TRPV4 and CGRP protein levels in lung and nasal mucosal tissues. The inhibitor group showed reduced IL-6 and IL-8 levels in serum, BALF, and NLF, reduced IL-6 in BALF, reduced IL-8 in NLF, and decreased TRPV4, SP, and CGRP protein levels in lung tissues and SP and CGRP protein levels in nasal mucosal tissues (
P
<0.05 or
P
<0.01). Compared with the TCM group, the inhibitor group had increased serum IgE, IL-6, and IL-8 levels, increased IL-6 level in BALF, and increased IL-8 levle in NLF, but decreased SP protein level in lung tissues and increased
TRPV4
and
SP
mRNA expression in lung tissues (
P
<0.01).
Conclusion
2
QTCD effectively reduces cough frequency in the UACS guinea pig model. Its mechanism may involve inhibiting the activation of the TRPV4 pathway, improving airway neurogenic inflammation, alleviating inflammatory responses, and reducing cough hypersensitivity.
关键词
Keywords
references
赖克方 . 慢性咳嗽 [M]. 2版 . 北京 : 人民卫生出版社 , 2019 : 241 .
LAI K , CHEN R , LIN J , et al . A prospective, multicenter survey on causes of chronic cough in China [J]. Chest , 2013 , 143 ( 3 ): 613 - 620 .
YU L , XU X , LV H , et al . Advances in upper airway cough syndrome [J]. Kaohsiung J Med Sci , 2015 , 31 ( 5 ): 223 - 228 .
CHUNG KF , MCGARVEY L , SONG WJ , et al . Cough hypersensitivity and chronic cough [J]. Nat Rev Dis Primers , 2022 , 8 ( 1 ): 45 .
BAHEKAR PC , SHAH JH , AYER UB , et al . Validation of guinea pig model of allergic rhinitis by oral and topical drugs [J]. Int Immunopharmacol , 2008 , 8 ( 11 ): 1540 - 1551 .
ZHONG S , NIE YC , GAN ZY , et al . Effects of Schisandra chinensis extracts on cough and pulmonary inflammation in a cough hypersensitivity guinea pig model induced by cigarette smoke exposure [J]. J Ethnopharmacol , 2015 , 165 : 73 - 82 . doi: 10.1016/j.jep.2015.02.009 http://dx.doi.org/10.1016/j.jep.2015.02.009 .
BROZMANOVA M , PLEVKOVA J , TATAR M , et al . Cough reflex sensitivity is increased in the guinea pig model of allergic rhinitis [J]. J Physiol Pharmacol , 2008 , 59 ( Suppl 6 ): 153 - 161 .
LEE K , BYUN J , KIM B , et al . TRPV4-mediated epithelial junction disruption in allergic rhinitis triggered by house dust mites [J]. Am J Rhinol Allergy , 2021 , 35 ( 4 ): 432 - 440 .
BHARGAVE G , WOODWORTH BA , XIONG G , et al . Transient receptor potential vanilloid type 4 channel expression in chronic rhinosinusitis [J]. Am J Rhinol , 2008 , 22 ( 1 ): 7 - 12 .
CHEUNG M , BAO W , BEHM DJ , et al . Discovery of GSK2193874: an orally active, potent, and selective blocker of transient receptor potential vanilloid 4 [J]. ACS Med Chem Lett , 2017 , 8 ( 5 ): 549 - 554 .
WANG Shouchuan's Experience in Pattern Identification and Treatment of Children's Upper Airway Cough Syndrome
A Clinical Observation on Wind-Coursing Lung-Diffusing and Phlegm-Transforming Throat-Disinhibiting Formula for 195 Cases of Upper Airway Cough Syndrome
Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"
Research on the Correlation Between "Tiangui (天癸)" and Female Reproductive Genetic Diseases
Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"
Related Author
汪受传
LI Tao
CHAI Erxi
ZHANG Mengyao
LIN Lili
DAI Qigang
LU Zhiyuan
WU Gang1
Related Institution
Affiliated Hospital of Nanjing University of Chinese Medicine
Institute of Pediatrics,Nanjing University of Chinese Medicine/Jiangsu Provincial Key Laboratory of Pediatric Respiratory Diseases(Traditional Chinese Medicine)
Jiangsu Provincial Research Institute of Chinese Medicine Schools
Wuxi Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine
First Affiliated Hospital of Nanjing University of Chinese Medicine